Page 30 - 中国全科医学2022-13
P. 30

http://www.chinagp.net   E-mail:zgqkyx@chinagp.net.cn  ·1563·


           ［21］RIECKERT A，REEVES D，ALTINER A，et al. Use of an electronic   ［32］CAUGHEY G E，TAIT K，VITRY A I，et al. Influence of
               decision support tool to reduce polypharmacy in elderly people with   medication risks and benefits on treatment preferences in older
               chronic diseases：cluster randomised controlled trial［J］. BMJ，  patients with multimorbidity［J］. Patient Prefer Adher，2017，11
               2020，369（6）：m1822. DOI：10.1136/bmj.m1822.            （1）：131-140. DOI：10.2147/PPA.S118836.
           ［22］SCHMIDT-MENDE K，ANDERSEN M，WETTERMARK B，        ［33］PAGE A T，CLIFFORD R M，POTTER K，et al. The feasibility
               et al. Educational intervention on medication reviews aiming to reduce   and effect of deprescribing in older adults on mortality and health：
               acute healthcare consumption in elderly patients with potentially   a systematic review and Meta-analysis［J］. Br J Clin Pharmacol，
               inappropriate medicines：a pragmatic open-label cluster-randomized   2016，82（3）：583-623. DOI：10.1111/bcp.12975.
               controlled trial in primary care［J］. Pharmacoepidemiol Drug Saf，  ［34］REEVE  E，SHAKIB  S，HENDRIX  I，et  al.  Harms  of
               2017，26（11）：1347-1356. DOI：10.1002/pds.4263.         deprescribing［J］. Med J Aust，2014，201（7）：386-389.
           ［23］QIU C，WINBLAD B，FRATIGLIONI L. The age-dependent relation of   DOI：10.5694/mja13.00200.
               blood pressure to cognitive function and dementia［J］. Lancet Neurol，  ［35］THOMPSON W，REEVE E，MORIARTY F，et al. Deprescribing：
               2005，4（8）：487-499. DOI：10.1016/S1474-4422(05)70141-1.  future directions for research［J］. Res Soc Admin Pharm，2019，
                                                                    15（6）：801-805. DOI：10.1016/j.sapharm.2018.08.013.
           ［24］MOONEN J E，FOSTER-DINGLEY J C，DE RUIJTER W，
                                                               ［36］SIROIS C，OUELLET N，REEVE E. Community-dwelling older
               et al. Effect of discontinuation of antihypertensive treatment in elderly
                                                                    people's attitudes towards deprescribing in Canada［J］. Res
               people on cognitive functioning——the DANTE study Leiden：a
                                                                    Social Adm Pharm，2017，13（4）：864-870. DOI：10.1016/j.
               randomized clinical trial［J］. JAMA Intern Med，2015，175（10）：
                                                                    sapharm.2016.08.006.
               1622-1630. DOI：10.1001/jamainternmed.2015.4103.
                                                               ［37］ANDERSON K，STOWASSER D，FREEMAN C，et al. Prescriber
           ［25］ROMSKAUG R，SKOVLUND E，STRAAND J，et al. Effect of
                                                                    barriers and enablers to minimising potentially inappropriate
               clinical geriatric assessments and collaborative medication reviews by
                                                                    medications  in  adults：a  systematic  review  and  thematic
               geriatrician and family physician for improving health-related quality
                                                                    synthesis［J］. BMJ Open，2014，4（12）：e006544. DOI：
               of life in home-dwelling older patients receiving polypharmacy：a
                                                                    10.1136/bmjopen-2014-006544.
               cluster randomized clinical trial［J］. JAMA Intern Med，2020，
                                                               ［38］KOULADJIAN L，GNJIDIC D，REEVE E，et al. Health care
               180（2）：181-189. DOI：10.1001/jamainternmed.2019.5096.
                                                                    practitioners' perspectives on deprescribing anticholinergic and
           ［26］SCHÄFER  I，KADUSZKIEWICZ  H，MELLERT  C，et  al.
                                                                    sedative medications in older adults［J］. Ann Pharmacother，
               Narrative medicine-based intervention in primary care to reduce
                                                                    2016，50（8）：625-636. DOI：10.1177/1060028016652997.
               polypharmacy：results from the cluster-randomised controlled trial
                                                               ［39］卫生部合理用药专家委员会 . 中国医师药师临床用药指南［M］.
               MultiCare AGENDA ［J］. BMJ Open，2018，8（1）：e017653.
                                                                    2 版 .  重庆：重庆出版社，2014.
               DOI：10.1136/bmjopen-2017-017653.
                                                               ［40］中国老年保健医学研究会老年合理用药分会 . 中国老年人潜在
           ［27］CAHIR  C，FAHEY  T，TEELING  M，et  al.  Potentially
                                                                    不适当用药判断标准（2017 版）［J］. 药物不良反应杂志，
               inappropriate prescribing and cost outcomes for older people：a
                                                                    2018，20（1）：2-8. DOI：10.376/cma.j.issn.1008-5734.2018.01.002.
               national population study［J］. Br J Clin Pharmacol，2010，69（5）：
                                                               ［41］吴慧利 . 老年住院糖尿病患者潜在不恰当用药现状及停药态度
               543-552. DOI：10.1111/j.1365-2125.2010.03628.x.
                                                                    问卷的适用性研究［D］. 郑州：郑州大学，2017.
           ［28］GILLESPIE P，CLYNE B，RAYMAKERS A，et al. Reducing
                                                               ［42］吴密彬，胡雁，朱叶卉，等 . 药物信念问卷在乳腺癌患者内分
               potentially inappropriate prescribing for older people in primary   泌治疗中的应用评价［J］. 护理学杂志，2014，29（1）：31-
               care：cost-effectiveness of the opti-script intervention［J］. Int J   33. DOI：10.3870/hlxzz.2014.01.031.
               Technol Assess Health Care，2017，33（4）：494-503. DOI：  ［43］GILLAIZEAU F，CHAN E，TRINQUART L，et al. Computerized
               10.1017/S0266462317000782.                           advice on drug dosage to improve prescribing practice［J］.
           ［29］SANYAL C，TURNER J P，MARTIN P，et al. Cost-effectiveness   Cochrane Database Syst Rev，2013，11：CD002894. DOI：
               of pharmacist-led deprescribing of NSAIDs in community-dwelling   10.1002/14651858.CD002894.
               older adults［J］. J Am Geriatr Soc，2020，68（5）：1090-  ［44］MEULENDIJK M C，SPRUIT M R，DRENTH-VAN MAANEN A
               1097. DOI：10.1111/jgs.16388.                         C，et al. Computerized decision support improves medication review
           ［30］ELLIOTT R A，PUTMAN K D，FRANKLIN M，et al. Cost        effectiveness：an experiment evaluating the STRIP Assistant's
               effectiveness of a pharmacist-led information technology intervention for   usability［J］. Drugs Aging，2015，32（6）：495-503. DOI：
               reducing rates of clinically important errors in medicines management in   10.1007/s40266-015-0270-0.
               general practices（PINCER）［J］. Pharmaco-economics，2014，32  ［45］FARRELL  B，POTTIE  K，ROJAS-FERNANDEZ  C  H，
               （6）：573-590. DOI：10.1007/s40273-014-0148-8.          et al. Methodology for developing deprescribing guidelines：
           ［31］EARL T R，KATAPODIS N D，SCHNEIDERMAN S R，et al.       using  evidence  and  GRADE  to  guide  recommendations  for
               Using deprescribing practices and the screening tool of older persons'   deprescribing［J］. PLoS One，2016，11（8）：e0161248.
               potentially inappropriate prescriptions criteria to reduce harm and   DOI：10.1371/journal.pone.0161248.
               preventable adverse drug events in older adults［J］. J Patient Saf，  （收稿日期：2021-11-25；修回日期：2022-03-05）
               2020，16（s1）：23-35. DOI：10.1097/PTS.0000000000000747.                            （本文编辑：陈俊杉）
   25   26   27   28   29   30   31   32   33   34   35